NCT07152197 Effects of Resistance Exercises in Hereditary Sensory-Motor Neuropathy (Charcot-Marie-Tooth Disease)
| NCT ID | NCT07152197 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Universidad de La Frontera |
| Condition | Polyneuropathy |
| Study Type | INTERVENTIONAL |
| Enrollment | 22 participants |
| Start Date | 2025-09-20 |
| Primary Completion | 2026-07-20 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 22 participants in total. It began in 2025-09-20 with a primary completion date of 2026-07-20.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to compare the effects of an 8-week resistance exercise training program on skeletal muscle quality, functional capacity, and quality of life in young individuals aged 15 to 29 years, with and without Hereditary Sensorimotor Polyneuropathy (HSPN). The main questions to answer are: What is the effect of an 8-week resistance exercise training program on skeletal muscle quality, functional capacity, and quality of life in young individuals with and without HSPN? Will the percentage of improvement after the program be greater in participants with HSPN compared to those without, due to greater baseline alterations? Researchers will compare the resistance exercise training program with baseline conditions to determine its effectiveness in improving skeletal muscle quality, functional capacity, and quality of life. Participants will undergo a supervised lower-limb resistance exercise program (3x/week) for 8 weeks. The intervention will include progressive loads from 60% to 80% of 1-Repetition Maximum (1RM), with exercises targeting the major lower limb muscle groups. All participants will complete pre- and post-intervention evaluations, including ultrasound assessment of muscle architecture, functional capacity tests, strength measurements, body composition analysis, and quality of life questionnaires.
Eligibility Criteria
Inclusion Criteria: * Men or women between 15 and 29 years of age with a diagnosis of hereditary sensorimotor polyneuropathy (HSPN) in any of its subtypes, living in the community (for experimental group). * Healthy men or women between 15 and 29 years of age living in the community (for control group). * Having active ankle movement within a range from plantarflexion to at least 0° of ankle dorsiflexion, allowing for strength training. Exclusion Criteria: * Osteoarticular or mobility impairments that prevent safe performance of resistance exercise training (e.g., ankle arthrodesis). * Use of nutritional supplements that may affect skeletal muscle regulation (leucine, glutamine, casein, whey protein, fatty acids, creatine, among others). * Untreated and/or uncontrolled chronic diseases or intellectual disability. * History of surgery * Participation in a resistance exercise training program within the past 6 months.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07152197 clinical trial?
This trial is open to participants of all sexes, aged 15 Years or older, up to 29 Years, studying Polyneuropathy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07152197 currently recruiting?
Yes, NCT07152197 is actively recruiting participants. Contact the research team at fernando.valenzuela@ufrontera.cl for enrollment information.
Where is the NCT07152197 trial being conducted?
This trial is being conducted at Temuco, Chile, Temuco, Chile.
Who is sponsoring the NCT07152197 clinical trial?
NCT07152197 is sponsored by Universidad de La Frontera. The trial plans to enroll 22 participants.